A global biopharmaceutical organization concluded while working with a less-experienced vendor that its three CNS trials were in danger of missing key project milestones including its eCOA launch date and first patient first visit (FPFV).

Signant, responding to their request for support, leveraged its comprehensive eCOA solutions as well as mature operational processes and experienced project teams to help the sponsor get back on track.

Applying a science-based, consultative approach along with technical solution design and delivery expertise, Signant helped the sponsor avoid schedule delays and ensure it captured accurate, reliable data for its CNS program.

Read the case study for details, and contact our team if your trials are in need of rescue.